Optimizing psychedelic therapy…there’s an app for that!

MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers

MINDCURE’s (MCUR) digital therapeutics platform could improve the psychedelic healing journey for both patients and clinicians!

The software application, iSTRYM, provides clinicians with a global database of therapy protocols, integration plans, and AI-driven data insights into patient journeys. The application connects to mobile and wearable devices to measure pateints’ biological response to the treatment, allowing clinicians to provide personalized care. iSTRYM also offers a Mindfulness Suite that patients can use to explore practices like breathwork and meditation to support their healing. 

This week, MINDCURE signed into an exclusive licensing agreement with ATMA Journey Centers, a private psychedelic therapy clinic in Calgary, which will grant MINDCURE access to anonymous patient data gathered from ATMA’s use of the platform.

PDF of article

The ATMA Urban Journey Clinic became the first clinic in Alberta to use psilocybin-assisted therapy and will become a Canada-wide training center for mental health professionals

Psychedelic drug therapy now offered at Calgary clinic, the first of its kind in Alberta

The ATMA Urban Journey Clinic in Calgary began psilocybin treatment for a terminal cancer patient, making it the first clinic in Alberta to use psychedelic therapy. Clinic CEO David Harder explains that psilocybin treatment brings out suppressed emotions, allowing patients and therapists to work through them together, whereas typical medications numb down the emotions. The cancer patient claims that he “couldn’t be more at peace” during the treatment, giving hope that psilocybin-assisted therapy will continue to gain traction. The clinic will become a training center for mental health professionals across the country.

PDF of article